Legal Representation
Attorney
Ian W. Gillies
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 26, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 26, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Nov 26, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 26, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Nov 26, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Nov 24, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 21, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 21, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 16, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Oct 16, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic pharmaceutical preparations, microbe-targeted pharmaceutical preparations, or host-targeted pharmaceutical preparations for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases; Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic pharmaceutical preparations, microbe-targeted pharmaceutical preparations, or host-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science
Class 005
Probiotic pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Host-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases
Class 042
Providing medical research and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic pharmaceutical products, microbe-targeted pharmaceutical products, or host-targeted pharmaceutical products; research in the fields of conducting clinical trials for others, biochemistry, and biotechnology
Class 044
Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic, microbe-targeted, or host-targeted pharmaceuticals
Additional Information
Design Mark
The mark consists of a stylized "V" positioned above the literal term "VERTERO".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
042
044